Efficacy of Cicaprost on metastasis in advanced tumor disease.
Schirner
M
M
Research Laboratories, Schering AG Berlin.
Lichtner
R B
RB
Graf
H
H
Schneider
M R
MR
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D011464:Epoprostenol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D008175:Lung Neoplasms / Q000473:pathology / Q000517:prevention & control / Q000556:secondary*; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis / Q000517:prevention & control*; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy / Q000473:pathology*; D009362:Neoplasm Metastasis / Q000517:prevention & control*; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D051381:Rats; D011916:Rats, Inbred F344; D011920:Rats, Inbred WF
D000970:Antineoplastic Agents; D011465:Prostaglandins, Synthetic; D011464:Epoprostenol; C043867:cicaprost